Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...
Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people ...
The Advances in Genome Biology and Technology (AGBT) meeting celebrated its 25 th anniversary in sunny Marco Island, Florida, with the customary mix of big name speakers addressing researchers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results